News Quantified

AVXL – anavex life sciences corp. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval Scenario [Seeking Alpha]

Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.

Anavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024 [Yahoo! Finance]

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.

0.2%

BEAT

1.8%

IN-LINE

-3.5%

BEAT

-10.5%

BEAT

Top News Gainers

12/4 Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Conference 30.6%

9/13 Form S-3/A ANAVEX LIFE SCIENCES 18.1%

3/23 Form DEFA14A ANAVEX LIFE SCIENCES 12.4%

2/14 Form SC 13G/A ANAVEX LIFE SCIENCES Filed by: Park West Asset Management LLC 11.9%

2/6 Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results and Provides Clinical Study Updates 9.2%

2/4 Anavex Life Sciences to Present and Participate in a Panel at the 2020 BIO CEO & Investor Conference 8.8%

2/3 Anavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Development Program for the Treatment of Rett Syndrome 5.1%

4/8 Form 8-K ANAVEX LIFE SCIENCES For: Apr 07 5.1%

12/5 Omeros, Anavex Results Positive, Protagonist Suffers Setback: The Good, Bad, And Ugly Of Biopharma [Seeking Alpha] 4.9%

6/18 Anavex Life Sciences Corp (NASDAQ: AVXL) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock. 4.5%

Top News Decliners

4/1 Anavex Life Sciences Corp (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock. -10.5%

9/27 Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study -9.7%

7/3 Form S-3 ANAVEX LIFE SCIENCES -8.9%

7/29 Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett Syndrome -8.7%

2/26 Anavex Life Sciences Corp (NASDAQ: AVXL) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -8.0%

6/13 Anavex Life Sciences Corp (NASDAQ: AVXL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%

2/24 Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS) -7.3%

2/6 Anavex Life Sciences' (AVXL) CEO Christopher Missling on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -7.2%

11/6 Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome -5.9%

3/31 Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19 -4.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day